Recently, a larger retrospective series on 81 resectable HCC showed shorter DFS and OS in patients with presence of TERT, CTNNB1 or TP53 mutations in plasma after curative hepatectomy [111]. This evidence concerns the gene TP53 and hepatocellular carcinoma.